Liu, J.;                     Chen, Q.-A.;                     Yang, Y.;                     Zhang, L.;                     Lin, W.;                     Hong, Y.;                     Gao, Y.    
        PAICS-Driven Purine Biosynthesis and Its Prognostic Implications in Lung Adenocarcinoma: A Novel Risk Stratification Model and Therapeutic Insights. Curr. Issues Mol. Biol. 2025, 47, 366.
    https://doi.org/10.3390/cimb47050366
    AMA Style
    
                                Liu J,                                 Chen Q-A,                                 Yang Y,                                 Zhang L,                                 Lin W,                                 Hong Y,                                 Gao Y.        
                PAICS-Driven Purine Biosynthesis and Its Prognostic Implications in Lung Adenocarcinoma: A Novel Risk Stratification Model and Therapeutic Insights. Current Issues in Molecular Biology. 2025; 47(5):366.
        https://doi.org/10.3390/cimb47050366
    
    Chicago/Turabian Style
    
                                Liu, Jinhui,                                 Qi-An Chen,                                 Yannan Yang,                                 Lin Zhang,                                 Weihao Lin,                                 Yuheng Hong,                                 and Yibo Gao.        
                2025. "PAICS-Driven Purine Biosynthesis and Its Prognostic Implications in Lung Adenocarcinoma: A Novel Risk Stratification Model and Therapeutic Insights" Current Issues in Molecular Biology 47, no. 5: 366.
        https://doi.org/10.3390/cimb47050366
    
    APA Style
    
                                Liu, J.,                                 Chen, Q.-A.,                                 Yang, Y.,                                 Zhang, L.,                                 Lin, W.,                                 Hong, Y.,                                 & Gao, Y.        
        
        (2025). PAICS-Driven Purine Biosynthesis and Its Prognostic Implications in Lung Adenocarcinoma: A Novel Risk Stratification Model and Therapeutic Insights. Current Issues in Molecular Biology, 47(5), 366.
        https://doi.org/10.3390/cimb47050366